Nuwellis (NUWE) Income from Continuing Operations (2011 - 2026)
Nuwellis' (NUWE) quarterly Income from Continuing Operations came in at -$4.8 million in Q2 2026, up 61.54% on a YoY basis from -$3.0 million in Q2 2025, and down 6.32% quarter-over-quarter from -$4.5 million in Q1 2026.
Analysis
Nuwellis (NUWE) Income from Continuing Operations (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Income from Continuing Operations for 16 consecutive years, with -$4.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Income from Continuing Operations rose 61.54% year-over-year to -$4.8 million; the trailing twelve-month figure through Jun 2026 stood at -$7.7 million (up 37.99% YoY), and the FY2025 full-year result was -$13.9 million, down 56.69% from the prior year.
- Income from Continuing Operations slipped to -$4.8 million in Q2 2026 per NUWE's latest filing, from -$4.5 million in the prior quarter.
- Across five years, Income from Continuing Operations topped out at $2.4 million in Q3 2024 and bottomed at -$12.6 million in Q2 2025.
- Historically, Income from Continuing Operations has averaged -$3.3 million across 5 years, with a median of -$4.1 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations jumped 552.21% in 2022, then plunged 214.65% in 2023.
- Over 5 years, Income from Continuing Operations stood at $1.1 million in 2022, then slumped by 214.65% to -$1.3 million in 2023, then soared by 165.84% to $850000.0 in 2024, then jumped by 45.53% to $1.2 million in 2025, then tumbled by 490.3% to -$4.8 million in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered -$4.8 million, -$4.5 million, and $1.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | -4.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.83 Mn |
| Mar 31, 2026 | -4.54 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 468,000.00 |
| Jun 30, 2025 | -12.55 Mn |
| Mar 31, 2025 | -3.01 Mn |
| Dec 31, 2024 | 850,000.00 |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | -7.73 Mn |
| Mar 31, 2024 | -4.33 Mn |
| Dec 31, 2023 | -1.29 Mn |
| Sep 30, 2023 | -3.37 Mn |
| Jun 30, 2023 | -4.85 Mn |
| Mar 31, 2023 | -6.49 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | -3.87 Mn |
| Jun 30, 2022 | -4.29 Mn |
| Mar 31, 2022 | -4.47 Mn |
| Dec 31, 2021 | -249,000.00 |
| Sep 30, 2021 | -5.27 Mn |